CANVECTOR LEADERSHIP: 2023 YEAR IN REVIEW, AND WHAT’S AHEAD FOR 2024 (CV-103)

Thursday, October 26, 2023

09:45 – 10:15 EST

Location: Palais, 513DEF

Target Audience: Basic/translational and clinical investigators, trainees (including graduate students, residents, and fellows), Trainees (including graduate students, residents, and fellows), Research personnel, and patient partners

Co-Chair(s)

Grégoire Le Gal (he/him/his)

Co-Director
CanVECTOR
University of Ottawa
Susan R. Kahn, MD, FRCPC, MSc (she/her/hers)

Professor of Medicine
McGill University
McGill University

Disclosure(s):

Grégoire Le Gal: BMS: Speaker/Honoraria (Terminated); Fresenius-Kabi: Consultant/Advisory Board (Terminated); Inari: Consultant/Advisory Board (Terminated); Leo Pharma: Speaker/Honoraria (Terminated); Pfizer: Speaker/Honoraria (Terminated); Sanofi: Consultant/Advisory Board (Ongoing)

Susan R. Kahn, MD, FRCPC, MSc: Alexion: Speaker/Honoraria (Terminated, January 1, 2023); Sanofi: Consultant/Advisory Board (Ongoing)